United States

Top 538 largest US Companies in the Biotechnology industry by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry from the United States by market capitalization with links to their reference stock.

United States Biotechnology Industry Analysis
Top US Companies United States Analysis
World Top Companies World Companies Analysis

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Top Biotechnology Companies from the United States as of Jan. 01, 2025

Download Excel

Rank Company Market Cap (USD) Country Sector Industry
211 Checkmate Pharmaceuticals, Inc. $231.4 M

(May 1, 2022)

 United States US Healthcare US Biotechnology
212 Abeona Therapeutics Inc. $229.3 M United States US Healthcare US Biotechnology
213 Larimar Therapeutics, Inc. $228.4 M United States US Healthcare US Biotechnology
214 Ocugen, Inc. $227.2 M United States US Healthcare US Biotechnology
215 Cardiff Oncology, Inc. $226.8 M United States US Healthcare US Biotechnology
216 4D Molecular Therapeutics, Inc. $225.1 M United States US Healthcare US Biotechnology
217 Fulcrum Therapeutics, Inc. $223.3 M United States US Healthcare US Biotechnology
218 Biomea Fusion, Inc. $221.1 M United States US Healthcare US Biotechnology
219 Nautilus Biotechnology, Inc. $221.0 M United States US Healthcare US Biotechnology
220 Zentalis Pharmaceuticals, Inc. $220.2 M United States US Healthcare US Biotechnology
221 Cidara Therapeutics, Inc. $207.0 M United States US Healthcare US Biotechnology
222 Zevra Therapeutics, Inc. $205.3 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
223 Gossamer Bio, Inc. $200.7 M United States US Healthcare US Biotechnology
224 MacroGenics, Inc. $198.3 M United States US Healthcare US Biotechnology
225 Inhibrx, Inc. $196.9 M United States US Healthcare US Biotechnology
226 Spectrum Pharmaceuticals, Inc. $192.9 M

(July 1, 2023)

 United States US Healthcare US Biotechnology
227 Merrimack Pharmaceuticals, Inc. $189.8 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
228 Inhibikase Therapeutics, Inc. $189.4 M United States US Healthcare US Biotechnology
229 ZIOPHARM Oncology, Inc. $187.1 M

(June 1, 2022)

 United States US Healthcare US Biotechnology
230 LogicBio Therapeutics, Inc. $185.8 M United States US Healthcare US Biotechnology
231 Harpoon Therapeutics, Inc. $178.6 M

(Jan. 1, 2024)

 United States US Healthcare US Biotechnology
232 Vaxart, Inc. $178.6 M United States US Healthcare US Biotechnology
233 Veru Inc. $177.1 M United States US Healthcare US Biotechnology
234 INmune Bio, Inc. $174.7 M United States US Healthcare US Biotechnology
235 Alector, Inc. $169.4 M United States US Healthcare US Biotechnology
236 Berkeley Lights, Inc. $168.7 M

(Jan. 1, 2023)

 United States US Healthcare US Biotechnology
237 Sorrento Therapeutics, Inc. $168.4 M

(April 1, 2023)

 United States US Healthcare US Biotechnology
238 Greenwich LifeSciences, Inc. $167.6 M United States US Healthcare US Biotechnology
239 Sutro Biopharma, Inc. $167.4 M United States US Healthcare US Biotechnology
240 Lyell Immunopharma, Inc. $166.8 M United States US Healthcare US Biotechnology

Top Biotechnology Companies from the United States as of Jan. 01, 2025

211. Checkmate Pharmaceuticals, Inc.

Company Profile: Checkmate Pharmaceuticals, Inc.
Market Cap (USD): $231.4 M (May 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

212. Abeona Therapeutics Inc.

Company Profile: Abeona Therapeutics Inc.
Market Cap (USD): $229.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

213. Larimar Therapeutics, Inc.

Company Profile: Larimar Therapeutics, Inc.
Market Cap (USD): $228.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

214. Ocugen, Inc.

Company Profile: Ocugen, Inc.
Market Cap (USD): $227.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

215. Cardiff Oncology, Inc.

Company Profile: Cardiff Oncology, Inc.
Market Cap (USD): $226.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

216. 4D Molecular Therapeutics, Inc.

Company Profile: 4D Molecular Therapeutics, Inc.
Market Cap (USD): $225.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

217. Fulcrum Therapeutics, Inc.

Company Profile: Fulcrum Therapeutics, Inc.
Market Cap (USD): $223.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

218. Biomea Fusion, Inc.

Company Profile: Biomea Fusion, Inc.
Market Cap (USD): $221.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

219. Nautilus Biotechnology, Inc.

Company Profile: Nautilus Biotechnology, Inc.
Market Cap (USD): $221.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

220. Zentalis Pharmaceuticals, Inc.

Company Profile: Zentalis Pharmaceuticals, Inc.
Market Cap (USD): $220.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

221. Cidara Therapeutics, Inc.

Company Profile: Cidara Therapeutics, Inc.
Market Cap (USD): $207.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

222. Zevra Therapeutics, Inc.

Company Profile: Zevra Therapeutics, Inc.
Market Cap (USD): $205.3 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

223. Gossamer Bio, Inc.

Company Profile: Gossamer Bio, Inc.
Market Cap (USD): $200.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

224. MacroGenics, Inc.

Company Profile: MacroGenics, Inc.
Market Cap (USD): $198.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

225. Inhibrx, Inc.

Company Profile: Inhibrx, Inc.
Market Cap (USD): $196.9 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

226. Spectrum Pharmaceuticals, Inc.

Company Profile: Spectrum Pharmaceuticals, Inc.
Market Cap (USD): $192.9 M (July 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

227. Merrimack Pharmaceuticals, Inc.

Company Profile: Merrimack Pharmaceuticals, Inc.
Market Cap (USD): $189.8 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

228. Inhibikase Therapeutics, Inc.

Company Profile: Inhibikase Therapeutics, Inc.
Market Cap (USD): $189.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

229. ZIOPHARM Oncology, Inc.

Company Profile: ZIOPHARM Oncology, Inc.
Market Cap (USD): $187.1 M (June 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

230. LogicBio Therapeutics, Inc.

Company Profile: LogicBio Therapeutics, Inc.
Market Cap (USD): $185.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

231. Harpoon Therapeutics, Inc.

Company Profile: Harpoon Therapeutics, Inc.
Market Cap (USD): $178.6 M (Jan. 1, 2024)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

232. Vaxart, Inc.

Company Profile: Vaxart, Inc.
Market Cap (USD): $178.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

233. Veru Inc.

Company Profile: Veru Inc.
Market Cap (USD): $177.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

234. INmune Bio, Inc.

Company Profile: INmune Bio, Inc.
Market Cap (USD): $174.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

235. Alector, Inc.

Company Profile: Alector, Inc.
Market Cap (USD): $169.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

236. Berkeley Lights, Inc.

Company Profile: Berkeley Lights, Inc.
Market Cap (USD): $168.7 M (Jan. 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

237. Sorrento Therapeutics, Inc.

Company Profile: Sorrento Therapeutics, Inc.
Market Cap (USD): $168.4 M (April 1, 2023)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

238. Greenwich LifeSciences, Inc.

Company Profile: Greenwich LifeSciences, Inc.
Market Cap (USD): $167.6 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

239. Sutro Biopharma, Inc.

Company Profile: Sutro Biopharma, Inc.
Market Cap (USD): $167.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

240. Lyell Immunopharma, Inc.

Company Profile: Lyell Immunopharma, Inc.
Market Cap (USD): $166.8 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Top 1-year algo backtest: +327.04% - Try Disfold DeepFinance for FREE now!

Stay in touch